Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Johnson and Johnson
UBS
Moodys
Express Scripts
Citi

Generated: July 20, 2019

DrugPatentWatch Database Preview

Patent: 8,383,578

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,383,578
Title:Peptides, derivatives and analogs thereof, and methods of using same
Abstract: Human proIslet Peptides (HIP) and HIP analogs and derivatives thereof, derived from or homologous in sequence to the human REG3A protein, chromosome 2p12, are able to induce islet neogenesis from endogenous pancreatic progenitor cells. Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome, eating disorders and the metabolic syndrome.
Inventor(s): Levetan; Claresa S. (Rosemont, PA), Upham; Loraine V. (Albuquerque, NM)
Assignee: CureDM Group Holdings, LLC (Wilmington, DE)
Application Number:13/168,461
Patent Claims:see list of patent claims

Details for Patent 8,383,578

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27 ➤ Try a Free Trial CureDM Group Holdings, LLC (Wilmington, DE) ➤ Try a Free Trial RX search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial CureDM Group Holdings, LLC (Wilmington, DE) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,383,578

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Covington
US Department of Justice
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.